Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,385
Total Claims
$980K
Drug Cost
788
Beneficiaries
$1,243
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-90%
Opioid rate vs peers
0.2% vs 2.2% avg
-12%
Cost per patient vs peers
$1,243 vs $1,411 avg
+10%
Brand preference vs peers
11.7% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
30
Opioid Claims
$169
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,553 claims · $750K
Generic: 11,732 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 102 | $127K |
| Apixaban | 266 | $117K |
| Sitagliptin Phosphate | 43 | $48K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $38K |
| Rivaroxaban | 54 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $28K |
| Fluticasone/Vilanterol | 53 | $27K |
| Empagliflozin | 46 | $24K |
| Umeclidinium Brm/Vilanterol Tr | 48 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $22K |
| Semaglutide | 13 | $20K |
| Rifaximin | 22 | $18K |
| Insulin Aspart | 24 | $17K |
| Sacubitril/Valsartan | 46 | $17K |
| Mirabegron | 89 | $16K |
Prescribing Profile
Patient Profile
77
Avg Age
56%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data